Atlas Trials

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants

Clinical trial NCT07522970 · RECRUITING

Trial details

NCT number
NCT07522970
Sponsor
LinGang Laboratory
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2026-04-20
Primary completion
2026-09-10
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.